Ruminant vaccine market seen reaching $4.4 billion by 2030

By AI, Created 9:52 AM UTC, May 20, 2026, /AGP/ – The Business Research Company says the global ruminant vaccines market will grow from $3.19 billion in 2025 to $4.4 billion by 2030, driven by livestock disease prevention, rising demand for animal products and new vaccine technologies. North America led the market in 2025, while Asia-Pacific is expected to grow fastest.

Why it matters: - Ruminant vaccines help protect cattle, sheep and other livestock from diseases that can cut productivity, disrupt food supplies and hurt farm economics. - The forecast points to steady demand for veterinary tools as global livestock production scales and producers look to reduce disease risk. - The market outlook also signals growing commercial momentum for newer vaccine formats, including recombinant, mRNA and DNA-based products.

What happened: - The Business Research Company released its Ruminant Vaccines Global Market Report 2026 – Market Size, Trends, And Forecast 2026–2030. - The report pegs the market at $3.19 billion in 2025 and $3.41 billion in 2026. - The market is projected to reach $4.4 billion by 2030. - The forecast implies a 6.9% CAGR in the near term and 6.6% CAGR over the 2026-2030 period. - North America held the largest share of the global market in 2025. - Asia-Pacific is forecast to be the fastest-growing region.

The details: - Ruminant vaccines are designed for herbivorous animals with four-chambered stomachs: rumen, reticulum, omasum and abomasum. - The vaccines target diseases including foot-and-mouth disease, brucellosis, bovine respiratory disease and clostridial infections. - The report ties historical growth to recurrent bovine disease outbreaks, limited access to modern vaccines, rising cattle and sheep populations, greater livestock-health awareness and expanding veterinary infrastructure. - The report says future growth will be supported by innovations in vaccine technology, more preventive livestock-health programs, higher veterinary research spending and digital vaccination monitoring. - Key trends highlighted in the report include stronger demand for foot-and-mouth disease vaccines, broader acceptance of mRNA and DNA-based vaccines, growth in subcutaneous and intramuscular delivery, wider use of livestock vaccination programs and integration with farm management software. - The report links market demand to rising global consumption of livestock products such as meat, milk, eggs, wool, leather, gelatin and animal fats. - The report cites October 2025 UK government data showing grazing livestock farms made up 30% of all farms in England’s lowland areas in 2024, while cereal farms covered 33% of agricultural land.

Between the lines: - The market forecast suggests livestock health is moving from a basic disease-control issue to a more technology-driven part of farm management. - The emphasis on recombinant, mRNA and digital tracking tools suggests the industry is broadening beyond traditional vaccine development. - The Asia-Pacific growth outlook likely reflects expanding livestock systems and rising demand for animal protein across the region.

What’s next: - Vaccine makers and livestock-health providers are likely to lean into preventive programs, digital monitoring and newer delivery methods as adoption expands. - Regional competition may intensify as Asia-Pacific demand accelerates and North America remains the largest established market. - More market attention is likely to shift toward foot-and-mouth disease prevention and vaccines suited for large-scale vaccination programs.

The bottom line: - Ruminant vaccines are moving toward a $4.4 billion market by 2030, with growth driven by disease prevention, livestock production demand and next-generation vaccine technology.

More information The full report